Safe and efficient peripheral blood stem cell collection in the smallest of children

Ther Apher. 1998 Feb;2(1):49-57. doi: 10.1111/j.1744-9987.1998.tb00073.x.

Abstract

To clarify the factors that may affect the peripheral blood stem cell (PBSC) collection in children weighing < or = 15 kg, a consecutive registry of 109 leukapheresis procedures was analyzed. Collections were performed on a COBE Spectra separator. In 65.1% of the procedures, the peripheral vein, together with a central catheter inserted routinely at diagnosis, or 2 peripheral veins were used to access/return. For 84.4% of the procedures, the extracorporeal line was primed with red blood cells. The median granulocyte-macrophage colony forming unit (CFU-GM) number derived from 1 patient's blood volume processed was 13.8 x 10(4)/kg. Six times, a collection series failed, always in children treated for > or = 26 weeks and 4 of those times in children weighing < or = 11 kg. The patient's age, diagnosis, duration of preleukapheresis treatment, and mobilization regimens did not significantly affect the collection yield. Twenty-four transplantations were performed. The median times to neutrophils >0.5 x 10(9)/L and platelets >20 x 10(9)/L were 13 and 20 days, respectively. We conclude that even in very small children, leukapheresis can be performed safely, allowing adequate PBSC collection for transplantation and/or in vitro manipulations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Blood Volume
  • Body Weight
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells*
  • Humans
  • Leukapheresis / adverse effects
  • Leukapheresis / instrumentation
  • Leukapheresis / methods*
  • Leukocyte Count
  • Male
  • Neoplasms / blood
  • Neoplasms / therapy*
  • Neutrophils
  • Platelet Count
  • Retrospective Studies
  • Treatment Outcome